Feed CCJ
CC

Cameco CCJ · NYSE

$81.52 -2.05% (-$1.71)

Summary

64 / 100 · Bulios Score

What speaks for it

  • Earnings per share grew by 83% a year over the last 3 years.
  • Out of every 100 CAD of revenue, 10 CAD is left as net profit.
  • It holds more cash than debt: $1.11B against $1.01B.
  • It has raised its dividend 6 years in a row and pays out only 30% of profit.

What to watch

  • The share price is above the Bulios Fair Price.
  • It earns only 4.0 CAD a year on every 100 CAD of invested capital.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Price

Is it expensive?

Looks expensive
Bulios Fair Price
Current price $81.52
5-year average P/E 122.3 18% higher
P/E today 145.0
Uranium industry median
P/E today 145.0

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Today you pay 145.0 CAD for 1 CAD of yearly profit. Over the last five years it was 122.3 CAD on average.

Valuation in detail

Is it growing?

Yes, fast

Revenue (CAD)

Diluted EPS (CAD)

  • Analyst estimate

Revenue grew by 14% a year over 5 years. Over the last 3 years it grew by 23% a year. For the next fiscal year analysts expect revenue to fall by 0.4%. Earnings per share grew by 83% a year over the last 3 years.

Growth in detail

Does it make money?

Very well

Where 100 CAD of revenue goes

Net profit, industry median (Uranium) 1.8 CAD

Out of every 100 CAD of revenue, 10 CAD is left as net profit.

Profitability in detail

Is it financially healthy?

Yes

Repaying all its debt would take 1.9 years of free cash flow. It holds more cash than debt.

Financial health in detail

Does it pay a dividend?

Small, safe
Yield
0.21%
Paid out of profit
30%
Raised in a row
6 years

You receive $0.17 per share a year. The company covers the payout with ease.

Dividends in detail

What do analysts expect?

Mildly positive

Today's price within the analysts' price targets

The average target of $135 is 66% above today's price. 67% of the analysts recommend buying.

Analysts in detail

What does it earn on?

Fiscal year 2025

By product

The company reports no revenue by product.

By region

United States brings in 95% of revenue.

Segments in detail

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.